Polymorphisms of T- cell leukemia 1A gene loci are not related to the development of adjuvant letrozole-induced adverse events in breast cancer

Letrozole, an aromatase inhibitor (AI), is the first-line adjuvant drug for treating hormone receptor-positive (HR+) breast cancer in postmenopausal women. However, harmful adverse events (AEs) and significant differences in drug response among individuals remain a significant problem in clinical ap...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Umamaheswaran, Gurusamy, Kadambari, Dharanipragada, Muthuvel, Suresh Kumar, Kumar, Naveena A. N., Dubashi, Biswajit, Aibor Dkhar, Steven, Adithan, Chandrasekaran
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7990231/
https://ncbi.nlm.nih.gov/pubmed/33760860
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0247989
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados